In the current study, salivary and serum NT-proBNP levels were prospectively measured in patients with stable chronic HF (CHF), acute decompensated HF (ADHF) admitted to hospital, and subjects with hypertension or obesity who presented with symptoms like dyspnoea but were not diagnosed with HF. The gene discussed is NPPB; the disease is congestive heart failure.